Prof. Dr. Heinz Redl (October 25th, 2019)
Prof. Dr. Heinz Redl, whose research focuses on diagnostic and therapeutic advancements for the rehabilitation of patients affected by accidents, gave a stimulating lecture on the topic of tissue regeneration after injuries and the contribution of hematologic cells.
Prof. Redl was director of the Ludwig Boltzmann Institute for Experimental and Clinical Traumatology within the Trauma Research Center of the AUVA and holds several other academic positions.
Prof. Emilio Casanova-Hevia (August 9th, 2019)
Prof. Emilio Casanova-Hevia from the Ludwig Boltzmann Institute for Cancer Research (LBI-CR) visited us on August 9th, 2019 and presented data about ERBB dependency in KRAS driven lung adenocarcinoma. He is Professor for “Transgenic Models in Cancer Research” at the Medical University of Vienna and an expert for generation of transgenic mouse models. We thank Prof. Casanova-Hevia for his time and interesting talk.
Prof. Karl Sotlar (May 29th, 2019)
We were very grateful to welcome Univ. Prof. Dr. Karl Sotlar, a great pathologist from the University Hospital Salzburg. He gave a very interesting and informative talk about “Microdissection in Hematopathology” followed by a fruitful discussion. Prof. Sotlar is an important collaboration partner of our research group and also member of the European Competence Network on Mastocytosis (ECNM).
Prof. Frank Siebenhaar (April 29th, 2019)
"Mast Cell Activation in Allergy, Atopy and Primary Mast Cell Disorders" was held by Professor Frank Siebenhaar. This lecture was very interesting review about allergy and its relationship to primary mast cell disorders. Professor Siebenhaar presented a various modalities of mast cell activation and possible therapeutic options, distinguishing between MC-dependent diseases, urticaria and type I allergy.
Prof. Dr. Wolfgang Kern (April 5th, 2019)
It was our pleasure to host a seminar entitled “Flow Cytometry and NGS in the Diagnosis of MDS and CMML” given by Prof. Dr. med. Wolfgang Kern today. Prof. Dr. Kern is the cofounder of the Munich Leukemia Laboratory (MLL) where he has been Head of the Immunophenotyping Department since 2005. He was previously in charge of immunophenotyping at the Laboratory for Special Leukemia Diagnostics, Clinic Munich-Großhadern. Prof. Dr. Kern has a long lasting research track record in identification of molecular markers in various hematologic malignancies and their application in diagnosis and prognostication as well as disease management. His talk focused on state-of-the-art diagnostic panels currently used or under development in improving the diagnosis of MDS and CMML. The seminar was followed by an inspiring discussion on potential future and ongoing collaborations. We thank Prof. Dr. Kern for his time and the wonderful talk.
Prof. Dr. Petri T. Kovanen (March 22nd, 2019)
Prof. Petri T. Kovanen from the University of Helsinki gave a great talk about “The Role of Mast Cells in Lipid Metabolism and Atherosclerosis” at one of our LBI Joint-seminars. His presentation was very interesting, and we had a fruitful discussion and exchanged a lot of ideas for research on mast cells. Prof. Kovanen is a member of the European Atherosclerosis Society (EAS) and contributes to annual EAS meetings and summer schools, where he teaches vascular biology to students.
Prof. Dr. Dominik Wolf (February 8th, 2019)
Prof. Dr. Dominik Wolf from the Medical University of Innsbruck visited Vienna to give a very informative talk within the scope of the LBI Joint-seminars. His presentation was entitled “Regulation and Impact of Immunological Checkpoints in Myeloid Neoplasms”. Prof. Dr. Wolf did his professorship at University Hospital Bonn and is now director of the Department of Internal Medicine V in Innsbruck. The clinical area of the Department is the diagnosis and treatment of benign and malignant diseases of the blood, lymph tissue and malignant solid tumors.